Brainstorm Cell Therapeutics (BCLI) Assets (2010 - 2026)
Brainstorm Cell Therapeutics (BCLI) recorded Assets of $788,000 in Q2 2026, down 69.3% from $2.57 million a year earlier but up 4.4% from the prior quarter.
Brainstorm Cell Therapeutics (BCLI) Assets (2010 - 2026) Analysis & Trends
At the end of FY2025, Brainstorm Cell Therapeutics reported Assets of $1.02 million, down 44.2% from FY2024.
- Annual Assets has declined for five straight years, with a five-year compound annual growth rate of -54.3% (FY2020 to FY2025).
- Across earlier years, Assets came in at $1.83 million in FY2024 (-56.5%), $4.21 million in FY2023 (-50.2%), $8.45 million in FY2022 (-71.1%) and $29.28 million in FY2021 (-42.9%).
- Quarterly Assets has ranged from $755,000 in Q1 2026 to $34.54 million in Q3 2021 over the past five years.
- On a year-over-year basis, Assets has declined for five consecutive quarters, with an average decline of 49.2% over the last eight quarters.
- Peak year-over-year performance for Assets in the last five years was growth of 6.7% in Q1 2025, against a decline of 78.9% in Q1 2026 at the low end.
- Per Business Quant, the preceding three quarters came in at $755,000 (Q1 2026), $1.02 million (Q4 2025) and $1.38 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.22 Bn | 1,133.81 Bn | 19.71 Bn | 142.28 Bn |
| 2 | Johnson & Johnson | 646.28 Bn | 566.14 Bn | 17.30 Bn | 197.43 Bn |
| 3 | AbbVie | 503.17 Bn | 476.28 Bn | 12.70 Bn | 135.12 Bn |
| 4 | Merck | 365.23 Bn | 319.60 Bn | 12.21 Bn | 129.80 Bn |
| 5 | Novartis Ag | 302.66 Bn | 266.65 Bn | 11.24 Bn | 122.03 Bn |
| 6 | Astrazeneca | 267.39 Bn | 241.08 Bn | 12.86 Bn | 115.83 Bn |
| 7 | Amgen | 241.61 Bn | 197.01 Bn | 7.24 Bn | 95.64 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | 49.36 Bn |
| 9 | Pfizer | 172.91 Bn | 119.55 Bn | 10.94 Bn | 201.13 Bn |
| 10 | Brainstorm Cell Therapeutics | 8.50 Mn | 8.43 Mn | - | 788,000.00 |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 788,000.00 |
| Mar 31, 2026 | 755,000.00 |
| Dec 31, 2025 | 1.02 Mn |
| Sep 30, 2025 | 1.38 Mn |
| Jun 30, 2025 | 2.57 Mn |
| Mar 31, 2025 | 3.57 Mn |
| Dec 31, 2024 | 1.83 Mn |
| Sep 30, 2024 | 2.03 Mn |
| Jun 30, 2024 | 5.68 Mn |
| Mar 31, 2024 | 3.35 Mn |
| Dec 31, 2023 | 4.21 Mn |
| Sep 30, 2023 | 5.68 Mn |
| Jun 30, 2023 | 5.75 Mn |
| Mar 31, 2023 | 7.87 Mn |
| Dec 31, 2022 | 8.45 Mn |
| Sep 30, 2022 | 13.25 Mn |
| Jun 30, 2022 | 18.96 Mn |
| Mar 31, 2022 | 25.79 Mn |
| Dec 31, 2021 | 29.28 Mn |
| Sep 30, 2021 | 34.54 Mn |
Brainstorm Cell Therapeutics Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=assets&ticker=BCLI&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "assets", "ticker": "BCLI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=assets&ticker=BCLI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();